» Articles » PMID: 21074760

Albumin and C-reactive Protein Levels Predict Short-term Mortality After Percutaneous Endoscopic Gastrostomy in a Prospective Cohort Study

Overview
Date 2010 Nov 16
PMID 21074760
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Percutaneous endoscopic gastrostomy (PEG) is a procedure with many complications that sometimes can be devastating. To give better advice to patients referred for PEG regarding risk of complications, important risk factors should be known.

Objective: To evaluate whether age, body mass index, albumin levels, C-reactive protein (CRP) levels, indication for PEG, and comorbidity influence the risk of mortality or peristomal infection after PEG insertion.

Design: Prospective cohort study from 2005 to 2009. Follow-up 14 days after PEG.

Setting: University hospital.

Patients: This study involved 484 patients referred for PEG.

Intervention: PEG.

Main Outcome Measurements: Mortality within 30 days and peristomal infection within 14 days after PEG insertion. All risk estimates were calculated with 95% CIs and adjusted for confounding.

Results: Among 484 patients, 58 (12%) died within 30 days after PEG insertion. Albumin <30 g/L (hazard ratio [HR], 3.46; 95% CI, 1.75-6.88), CRP ≥10 (HR, 3.47; 95% CI, 1.68-7.18), age ≥65 years (HR, 2.26; 95% CI, 1.20-4.25) and possibly body mass index <18.5 (HR, 2.04; 95% CI, 0.97-4.31) were associated with increased mortality. Patients with a combination of low albumin and high CRP levels had a mortality rate of 20.5% compared with 2.6% among patients with normal values, rendering an over 7-fold increased adjusted risk of mortality (HR, 7.45; 95% CI, 2.62-21.19).

Limitations: Missing data in some study variables. Although the sample size was large, weaker associations could not be established.

Conclusion: The combination of low albumin and high CRP levels indicates a substantially increased short-term mortality risk after PEG, which should be considered in decision making.

Citing Articles

One-Year Mortality After Percutaneous Endoscopic Gastrostomy: The Prognostic Role of Nutritional Biomarkers and Care Settings.

Bilgic N, Kahveci G, Ozsenel E, Basat S Nutrients. 2025; 17(5).

PMID: 40077774 PMC: 11901879. DOI: 10.3390/nu17050904.


Impact of severe dysphagia on overall survival after percutaneous endoscopic gastrostomy.

Shimamoto K, Matsui R, Nishiyama Y, Nishino K, Ban H Sci Rep. 2025; 15(1):3617.

PMID: 39875545 PMC: 11775191. DOI: 10.1038/s41598-025-88097-y.


Measurement of changes in serum-based inflammatory indicators to monitor response to nivolumab monotherapy in advanced gastric cancer: a multicenter retrospective study.

Inukai M, Nishi T, Matsuoka H, Matsuo K, Suzuki K, Serizawa A BMC Cancer. 2024; 24(1):1121.

PMID: 39251991 PMC: 11382521. DOI: 10.1186/s12885-024-12813-6.


Pre-Stroke Frailty and Outcomes following Percutaneous Endoscopic Gastrostomy Tube Insertion.

Gupta K, Williams E, Warburton E, Evans N Healthcare (Basel). 2024; 12(16).

PMID: 39201117 PMC: 11353361. DOI: 10.3390/healthcare12161557.


Factors Associated With Short-Term Complications After Percutaneous Endoscopic Gastrostomy Tube Insertion: A Retrospective Cohort Study.

Shehata M, Al Hosani I, Ahmed I, Abu Alkas H, Khaddam O, Aljanahi A Cureus. 2024; 16(3):e55741.

PMID: 38463403 PMC: 10920060. DOI: 10.7759/cureus.55741.